nodakenin has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, B; Kuang, G; Li, N; Lu, M; Mi, Y; Tan, K; Wang, L; Xu, X; Yan, K; Yi, N; Zhang, B | 1 |
Li, J; Tan, R; Wang, L; Zhao, S; Zhong, X | 1 |
Li, J; Liao, Y; Lin, X; Tan, R; Wang, L; Zhong, X | 1 |
3 other study(ies) available for nodakenin and Disease Models, Animal
Article | Year |
---|---|
Nodakenin attenuates cartilage degradation and inflammatory responses in a mice model of knee osteoarthritis by regulating mitochondrial Drp1/ROS/NLRP3 axis.
Topics: Animals; Cartilage, Articular; Chondrocytes; Coumarins; Disease Models, Animal; Dynamins; Mice; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Osteoarthritis, Knee; Reactive Oxygen Species | 2022 |
Nodakenin alleviated obstructive nephropathy through blunting Snail1 induced fibrosis.
Topics: Angelica; Animals; Anti-Inflammatory Agents; Coumarins; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Kidney; Kidney Failure, Chronic; Macrophages; Mice; NF-kappa B; Phosphorylation; Plant Roots; Signal Transduction; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta1; Ureteral Obstruction | 2020 |
Nodakenin alleviates renal ischaemia-reperfusion injury via inhibiting reactive oxygen species-induced NLRP3 inflammasome activation.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Disease Models, Animal; Drug Discovery; Glucosides; Inflammasomes; Interleukin-1beta; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2021 |